These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2775516)

  • 1. Functional impairment of protein C activity during haemodialysis--a new mechanism of extracorporeal thrombogenesis.
    Knudsen F; Sørensen J; Nielsen AH; Dyerberg J
    Blood Purif; 1989; 7(4):230-2. PubMed ID: 2775516
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of seasonal and meteorological conditions on the incidence of thrombotic haemodialysis shunt occlusions.
    Stoeckelhuber BM; Wiesmann M; Kirk E; Suden K; Weiss HD
    Thromb Haemost; 2002 Dec; 88(6):1074-6. PubMed ID: 12529767
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
    Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH
    Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein C and its inhibitors during hemodialysis.
    Arik N; Ozdemir O; Akpolat T; Arinsoy T; Ozcebe O; Dündar S; Yasavul U; Turgan C; Caglar S
    Nephron; 1992; 60(4):488. PubMed ID: 1584328
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: A randomized cross-over trial.
    Kurtkoti J; Bose B; Hiremagalur B; Sun J; Cochrane T
    Nephrology (Carlton); 2016 Aug; 21(8):663-8. PubMed ID: 26609786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infected intracardiac thrombi: complication of vascular access in haemodialysis patients.
    Peeters P; Colle I; Van der Niepen P; Verbeelen D
    Nephrol Dial Transplant; 1995; 10(6):909-10. PubMed ID: 7566632
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative survey on the incidence of kidney graft primary vascular thrombosis among CAPD and haemodialysis patients.
    Escuin F; Del Peso G; Pérez Fontán M; Rodriguez-Carmona A; Martínez A; Lanuza M; Hortal L; Fernández AM; Albero MD; Pérez Contreras J; Selgas R
    Nephrol Dial Transplant; 1996 Sep; 11(9):1896-7. PubMed ID: 8918657
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemodialysis access without thrombosis: is it possible?
    Blankestijn PJ; Bosman PJ; Boereboom FT
    Nephrol Dial Transplant; 1996 Dec; 11(12):2394-7. PubMed ID: 9017609
    [No Abstract]   [Full Text] [Related]  

  • 10. An infected right atrial thrombus--a new complication of haemodialysis associated subclavian vein catheterisation.
    Korzets A; Katz S; Chagnac A; Katz M; Gafter U; Zevin D; Levi J
    Nephrol Dial Transplant; 1994; 9(11):1652-4. PubMed ID: 7870359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local low-dose streptokinase therapy of shunt thrombosis in chronic hemodialysis patients].
    Grohmann G; Stein G; Günther E; Sperschneider H; Fünfstück R
    Z Urol Nephrol; 1981 Aug; 74(8):597-601. PubMed ID: 7303985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further investigations of the defective protein C in hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis.
    Sørensen PJ; Nielsen AH; Knudsen F; Dyerberg J
    Blood Purif; 1989; 7(4):218-22. PubMed ID: 2775514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].
    Quintana LF; Coll E; Monteagudo I; Collado S; López-Pedret J; Cases A
    Nefrologia; 2005; 25(4):442-4. PubMed ID: 16231514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive bladder haemorrhage after thrombolytic therapy in a haemodialysis patient with secondary amyloidosis.
    Quittenbaum S; Grefberg N
    Nephrol Dial Transplant; 1993; 8(10):1174-5. PubMed ID: 8272235
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous Renal Replacement Therapy and Anticoagulation: What Are the Options?
    Dirkes S; Wonnacott R
    Crit Care Nurse; 2016 Apr; 36(2):34-41. PubMed ID: 27037337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein in haemodialysis patients with dialysis arthropathy.
    Sethi D; Muller BR; Brown EA; Maini RN; Gower PE
    Nephrol Dial Transplant; 1988; 3(3):269-71. PubMed ID: 3140099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombotic complications of arterio-venous fistulas in chronically hemodialysed patients].
    Kawecka A; Prajs J; Lipiński J; Białko M
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():60-4. PubMed ID: 9424928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right atrial thrombus as a complication of a temporary haemodialysis catheter--a potentially avoidable complication.
    Dreyer G; Bingham C
    Nephrol Dial Transplant; 2005 Feb; 20(2):474-5. PubMed ID: 15673710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences in the performance of the Scribner-Quinton shunt for extracorporeal dialysis].
    Hach W; Brass H
    Med Welt; 1966 Apr; 16():874-7. PubMed ID: 5957312
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enoxaparin in haemodialysis].
    Olszowska A; Zelichowski G
    Pol Merkur Lekarski; 2002 Nov; 13(77):433-6. PubMed ID: 12621768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.